Actualizaciones regulatorias

Novedades regulatorias de FDA, EMA, TGA y organismos globales

#DIVALPROEX ×

Actualizaciones regulatorias

25 sept 2026•1 min de lectura

FDA Approves DIVALPROEX SODIUM (ANDA078853)

FDA grants approval for DIVALPROEX SODIUM tablets (ANDA078853) by Bionpharma Inc., with oral delayed‑release 125 mg, 250 mg and 500 mg equivalents.